Recent News

• 04.09.2025 - 24th Annual Needham VirtualHealthcare Conference 2025
• 04.02.2025 - Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
• 03.28.2025 - Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
• 03.28.2025 - Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
• 03.12.2025 - Leerink Partners Global Healthcare Conference 2025
• 03.07.2025 - Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
• 03.07.2025 - Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
• 03.06.2025 - Lexicon Pharmaceuticals 4th Quarter 2024 Results Conference Call
• 03.06.2025 - Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Recent Filings

• 03.28.2025 - 8-K Current report
• 03.25.2025 - PRE 14A Other preliminary proxy statements
• 03.07.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report